Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579969 · ClinicalTrials.gov registry record · Phase 2
Comparison of Latanoprost Vs. Timolol
A Phase 2 study, sponsored by University of Nebraska.
- Terminated
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00579969 is a Phase 2 study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 30 participants.
The verdict
NCT00579969, a Phase 2 study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The primary purpose of this study is to show, through a controlled masked clinical study of subjects with ocular hypertension (OHT), that latanoprost increases the low uveoscleral drainage of aqueous humor back to normal levels, and timolol maleate reduces the formation of aqueous humor below normal. Both of these mechanisms will effectively reduce intraocular pressure (IOP). The secondary purpose is to assess the effects of both latanoprost and timolol maleate on the fluorophotometric outflow facility, and episcleral venous pressure and on all parameters over time.
Interventions
- DRUG Latanoprost
- DRUG Timolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2003-12 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579969
The ClinicalTrials.gov registry entry for NCT00579969 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Latanoprost is the first listed.
NCT00579969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00579969 about?
NCT00579969 is a clinical study titled "Comparison of Latanoprost Vs. Timolol". The primary purpose of this study is to show, through a controlled masked clinical study of subjects with ocular hypertension (OHT), that latanoprost increases the low uveoscleral drainage of aqueous humor back to normal levels, and timolol maleate reduces the formation of aqueous humor below normal...
What is the current status of trial NCT00579969?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2003-12. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00579969?
The interventions under investigation include: Latanoprost (DRUG), Timolol (DRUG).
Who is sponsoring clinical trial NCT00579969?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.